Latin America, Middle East & Africa Facial Fat Transfer Market to Grow with a CAGR of 11.4%, 2019-2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Latin America, Middle East & Africa Facial Fat Transfer Market (2019-2025)" report has been added to ResearchAndMarkets.com's offering.

The Latin America, Middle East and Africa Facial Fat Transfer Market is expected to witness market growth of 11.4% CAGR during the forecast period (2019-2025).

The Middle East and Africa region have been estimated to contribute to worldwide market development. Nonetheless, due to the under-developed status of various African countries, growth is minimal. The Middle East is expected to be responsible for the growth of these global segments due to the high prevalence and acceptance of cosmetic procedures among women in the region. Fat Transfer is not just a bioinert material, but a metabolic active substance and a live graft. Facial Fat Transfer procedures are therefore done only by experts or cosmetic surgeons. The procedure consists of collecting small amounts of fat from other parts of the body, such as the thighs, abdomen or hips, and injecting it into areas of the face that are depleted. It reduces lines and reshapes the face, improving the overall youthfulness of facial appearance.

Fat transfer procedures have been extremely popular, where the stem cells stored in body fat are harvested and transferred to the facial folds for a youthful and plumper look. Microneedling is yet another method adopted for the same. The micro-needling procedure is also called as the collagen induction therapy and is a minimally-invasive skin rejuvenation treatment that uses the Skin Pen, a tool which includes fine needles. The needles are used to gently puncture the skin and activate the body's natural wound healing mechanism. This results in a remodeling of the skin surface, such as the formation of collagen and elastin, providing the skin a smooth and youthful look.

Based on Donor Site, the market is segmented into Flank, Thigh and Abdomen. Based on End Use, the market is segmented into Clinics & surgery centers and Hospitals. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC, Integra LifeSciences Holdings Corporation, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, Ranfac Corporation, Cytori Therapeutics, Inc., Suneva Medical, Inc., Dr. Korman Laboratories Ltd., Scivision Biotech, Inc., and Teoxane Laboratories SA.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

1.1 Market Definition

1.2 Objectives

1.3 Market Scope

1.4 Segmentation

1.4.1 LAMEA Facial Fat Transfer Market, by Donor Site

1.4.2 LAMEA Facial Fat Transfer Market, by End Use

1.4.3 LAMEA Facial Fat Transfer Market, by Country

1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction

2.1.1 Overview

2.1.2 Market Composition and Scenario

2.2 Key Factors Impacting the Market

2.2.1 Market Drivers

2.2.2 Market Restraints

Chapter 3. LAMEA Facial Fat Transfer Market by Donor Site

3.1 LAMEA Flank Facial Fat Transfer Market by Country

3.2 LAMEA Thigh Facial Fat Transfer Market by Country

3.3 LAMEA Abdomen Facial Fat Transfer Market by Country

Chapter 4. LAMEA Facial Fat Transfer Market by End-Use

4.1 LAMEA Clinics & surgery centers Market by Country

4.2 LAMEA Hospitals Market by Country

Chapter 5. LAMEA Facial Fat Transfer Market by Country

5.1 Brazil Facial Fat Transfer Market

5.2 Argentina Facial Fat Transfer Market

5.3 UAE Facial Fat Transfer Market

5.4 Saudi Arabia Facial Fat Transfer Market

5.5 South Africa Facial Fat Transfer Market

5.6 Nigeria Facial Fat Transfer Market

5.7 Rest of LAMEA Facial Fat Transfer Market

Chapter 6. Company Profiles

6.1 Allergan PLC

6.2 Integra LifeSciences Holdings Corporation

6.3 Bausch Health Companies, Inc.

6.4 Ipsen Pharma Biotech SAS

6.5 Ranfac Corporation

6.6 Cytori Therapeutics, Inc.

6.7 Suneva Medical, Inc.

6.8 Dr. Korman Laboratories Ltd.

6.9 Scivision Biotech, Inc.

6.10 Teoxane Laboratories SA

For more information about this report visit https://www.researchandmarkets.com/r/2cw3ux